相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Predictors of Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Hemodialysis Patients
Kamyar Kalantar-Zadeh et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Route of Epoetin Administration Influences Hemoglobin Variability in Hemodialysis Patients
Tejas Patel et al.
AMERICAN JOURNAL OF NEPHROLOGY (2009)
Hemoglobin Variability in Anemia of Chronic Kidney Disease
Kamyar Kalantar-Zadeh et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
Marc A. Pfeffer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Mortality in renal transplant recipients given erythropoietins to increase haemoglobin concentration: cohort study
Georg Heinze et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Association of Hemoglobin Variability and Mortality among Contemporary Incident Hemodialysis Patients
Steven M. Brunelli et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
History-adjusted marginal structural analysis of the association between hemoglobin variability and mortality among chronic hemodialysis patients
Steven M. Brunelli et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Hemoglobin level variability: Associations with mortality
David T. Gilbertson et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients
Ryan D. Kilpatrick et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Hemoglobin variability and mortality in ESRD
Wei Yang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Correction of anemia with epoetin alfa in chronic kidney disease
Ajay K. Singh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Normalization of hemoglobin level in patients with chronic kidney disease and anemia
Tilman B. Drueke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Pharmacokinetics and pharmacodynamics of intravenous and subcutaneous Continuous Erythropoietin Receptor Activator (CERA) in patients with chronic kidney disease
Iain C. Macdougall et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients
Deborah L. Regidor et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Structured conversion from thrice weekly to weekly erythropoietic regimens using a computerized decision-support system: A randomized clinical study
C Tolman et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
A flexible B-spline model for multiple longitudinal biomarkers and survival
ER Brown et al.
BIOMETRICS (2005)
Causes and consequences of the reverse epidemiology of body mass index in dialysis patients
K Kalantar-Zadeh
JOURNAL OF RENAL NUTRITION (2005)
Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)
F Locatelli et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Hemoglobin variability in epoetin-treated hemodialysis patients
JS Berns et al.
KIDNEY INTERNATIONAL (2003)
Influence of the cyclic variation of hydration status on hemoglobin levels in hemodialysis patients
V Bellizzi et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2002)
Optimizing the use of erythropoietic agents - pharmacokinetic and pharmacodynamic considerations
IC Macdougall
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
分享论文
